Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells
- PMID: 20189402
- PMCID: PMC3310921
- DOI: 10.1016/j.bmc.2010.01.069
Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells
Abstract
Various 2-benzylidene-6-(nitrobenzylidene)cyclohexanones were prepared as candidate cytotoxins in which the nitro group was located in the ortho, meta and para positions leading to series 1-3, respectively. The CC(50) values towards human HSC-2 and HSC-4 oral squamous cell carcinomas as well as human HL-60 promyelocytic leukemic cells are in the low micromolar range in general. On the other hand, most of the compounds afforded clear evidence of being far less toxic towards human HGF gingival fibroblasts, HPC pulp cells and HPLF periodontal ligament fibroblasts which are non-malignant cells. Selectivity index (SI) figures were generated which are the ratios of the average CC(50) values towards normal cells and the CC(50) figure towards a malignant cell line. Huge SI values were obtained for many of the compounds. In particular 1c, 2f, 3c and 3g which have average SI values of >76, >38, 124 and 341, respectively, are clearly lead molecules affording direction for amplification of this area of study. A lead compound 1c caused internucleosomal DNA fragmentation and activation of caspase-3 in HL-60 cells but not in HSC-2 carcinomas. In a short-term toxicity study, doses up to and including 300 mg/kg of the majority of the compounds prepared in this study did not cause any mortalities to mice. Some guidelines for development of these tumor-selective cytotoxins are presented.
Copyright 2010 Elsevier Ltd. All rights reserved.
Figures




Similar articles
-
1-(3-aminomethyl-4-hydroxyphenyl)-3-pyridinyl-2-propen-1-ones: a novel group of tumour-selective cytotoxins.J Enzyme Inhib Med Chem. 2013 Oct;28(5):974-80. doi: 10.3109/14756366.2012.700927. Epub 2012 Jul 18. J Enzyme Inhib Med Chem. 2013. PMID: 22803675
-
6-Benzylidene-2-[4-(pyridin-3-ylcarboxy)benzylidene]cyclohexanones: A novel cluster of tumour-selective cytotoxins.Bioorg Med Chem Lett. 2017 Apr 1;27(7):1611-1615. doi: 10.1016/j.bmcl.2017.02.016. Epub 2017 Feb 10. Bioorg Med Chem Lett. 2017. PMID: 28238612
-
3,5-Bis(benzylidene)-1-[4-2-(morpholin-4-yl)ethoxyphenylcarbonyl]-4-piperidone hydrochloride: a lead tumor-specific cytotoxin which induces apoptosis and autophagy.Bioorg Med Chem Lett. 2010 Feb 1;20(3):912-7. doi: 10.1016/j.bmcl.2009.12.076. Epub 2009 Dec 24. Bioorg Med Chem Lett. 2010. PMID: 20064715 Free PMC article.
-
1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-Bis(3,4,5-Trimethoxybenzylidene)- 4-Piperidone Hydrochloride and Related Compounds: Potent Cytotoxins Demonstrate Greater Toxicity to Neoplasms than Non- Malignant Cells.Med Chem. 2022;18(9):1001-1012. doi: 10.2174/1573406418666220322154110. Med Chem. 2022. PMID: 35319387
-
1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets.Curr Med Chem. 2009;16(16):2001-20. doi: 10.2174/092986709788682218. Curr Med Chem. 2009. PMID: 19519378 Free PMC article. Review.
Cited by
-
Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts.Molecules. 2021 Nov 25;26(23):7132. doi: 10.3390/molecules26237132. Molecules. 2021. PMID: 34885719 Free PMC article.
-
Dienone Compounds: Targets and Pharmacological Responses.J Med Chem. 2020 Dec 24;63(24):15075-15093. doi: 10.1021/acs.jmedchem.0c00812. Epub 2020 Nov 4. J Med Chem. 2020. PMID: 33146523 Free PMC article.
References
-
- Pati HN, Das U, Sharma RK, Dimmock JR. Mini-Rev Med Chem. 2007;7:131. - PubMed
-
- Dimmock JR, Raghavan SK, Logan BM, Bigam GE. Eur J Med Chem. 1983;18:248.
-
- Okey AB, Harper PA. In: Principles of Medical Pharmacology. 7. Kalant H, Grant DM, Mitchell J, editors. Elsevier; Toronto, Canada: 2007. p. 902.
-
- Kamiya D, Uchihata Y, Ichikawa E, Kato K, Umezawa K. Bioorg Med Chem. 2005;15:1111. - PubMed
-
- Samudio I, Konopleva M, Hail N, Jr, Shi YX, McQueen T, Hsu T, Evans R, Honda T, Gubble GW, Sporn M, Gilbert HF, Sabe S, Andreeff M. J Biol Chem. 2005;280:36273. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials